New blood test aims to slash unnecessary antibiotics in ER lung infections

NCT ID NCT05762302

Recruiting now Disease control Sponsor: MeMed Diagnostics Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new blood test called MeMed BV in about 1,300 adults with suspected lower respiratory infections (like bronchitis or pneumonia) in the ER. The goal is to see if the test helps doctors prescribe antibiotics only when truly needed, reducing unnecessary use. Participants are randomly assigned to get the test result or standard care, and researchers track antibiotic prescriptions and health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOWER RESPIRATORY TRACT INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lower respiratory tract disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LOWER RESPIRATORY TRACT INFECTION

Contacts and locations

Locations

Carmel Medical Center
RECRUITING

Haifa, North, Israel
Lin Medical Center
NOT_YET_RECRUITING

Haifa, Israel
MCW
RECRUITING

Milwaukee, Wisconsin, 53226, United States
Maimonides Medical Center
RECRUITING

Brooklyn, New York, 11219, United States
Medical University South Carolina
RECRUITING

Charleston, South Carolina, 29425, United States
Philadelphia Thomas Jefferson ED
RECRUITING

Philadelphia, Pennsylvania, 19107, United States
Stony Brook University Hospital
RECRUITING

Stony Brook, New York, 11794, United States
UT Southwestern Medical Center
RECRUITING

Dallas, Texas, 75390, United States
University of Florida-Jacksonville
RECRUITING

Jacksonville, Florida, 32209, United States
University of Kansas Medical Center
RECRUITING

Kansas City, Kansas, 66160, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.